HWI group
Kerstin Niemann is currently working as a Project Leader at HWI pharma services GmbH since January 2018. Prior to this, Kerstin was a Senior Scientist Quality Control at Phast GmbH from January 2016 to December 2017. Their responsibilities included quality control of drug substances and drug products under cGMP conditions, focusing on HPLC/UPLC method development, qualification and validation, as well as cleaning validation. Before their industry experience, Kerstin worked as a Postdoc at Forschungszentrum Jülich from October 2013 to September 2015. Kerstin holds a Dr. rer. nat. in Biochemie from the University of Tübingen (2009-2013) and a Diplom in Biochemie from the University of Regensburg (2003-2009).
This person is not in any teams
HWI group
With 150 colleagues at 3 sites in Ruelzheim, Frankfurt and Appenweier we look back on 30 years of experience. We offer a service portfolio ranging from product development, analytical development and quality control, manufacturing of clinical batches and smaller market batches to drug safety and GxP services. Together with network partners, HWI also supports clinical and preclinical studies. Our technology platform for parenteral, nasal and oral applications focuses on the development of innovative and affordable drugs with a special focus on poorly soluble small and large molcules. Our purpose is with novel technologies and innovative services to drive the development of highly effective medicines for everyone to improve peoples lives. Imprint: https://www.hwi-group.de/en/imprint.html Data protection information: https://www.hwi-group.de/en/company/infocenter.html GTC: https://www.hwi-group.de/en/company/infocenter.html